Gxene Biotech has been engaged in protein expression research for many years and has rich experience in stable cell line development. We can provide customers with high-quality stable cell line construction services. Our technical team strictly controls every experimental step, which can effectively improve the production capacity of stable cell lines, improve experimental results, and ensure product quality. The stable cell lines we prepare are suitable for various research applications, such as recombinant protein and antibody production, gene editing, functional research, etc.
Gxene Biotech has established a comprehensive cell biology technology platform and a standard cell laboratory. It has a complete range of cell bank resources and can provide you with more than 300 types of tumor cells and primary cells that have undergone full STR authentication. These cell lines cover nearly 30 or more cancer types and primary cells, including lung cancer, small cell lung cancer, cervical cancer, gastric cancer, liver cancer, colon cancer, osteosarcoma, glioblastoma, neuroblastoma, etc. Each cell line has undergone strict management and validation and is easy to infect with lentivirus or adenovirus, facilitating gene manipulation and providing a large number of selectable cell models for your scientific research and industrial production.
Lentiviral Infection System:
The lentiviral infection system is a gene vector system developed based on HIV. It can infect dividing and non-dividing cells and effectively integrate exogenous genes into host chromosomes, thereby achieving persistent expression of exogenous genes with high safety. Gxene Biotech uses a second-generation self-inactivating lentiviral infection vector system and has developed multiple gene manipulation vector systems; at the same time, it has established lentivirus purification processes for various purity requirements and can package lentiviruses with different purity requirements. The company's platform has extensive experience in lentiviral infection of various cell types and has established standard experimental workflows for constructing stable cell lines from different cell types, enabling us to provide you with high-quality stable cell line construction services.
Service Content:
Gxene Biotech can design lentiviral vectors for target genes with different operation types according to customer needs, including gene knockdown (KD), gene overexpression (OE), gene overexpression (Cas9-SAM), site-specific gene knockout (KO), and site-specific gene knock-in (KI). It can also package and prepare high-titer lentiviral particles with different purity requirements (≥1E+8 IU/ml), infect target cells, and screen and prepare corresponding stable cell lines to meet customers' research or clinical experimental needs.
| Type | Service Item | Technical Advantages |
| Gene Knockout | CRISPR/Cas9 Knockout Cell Line Construction Service | The CRISPR/Cas9 system is currently a widely used gene editing technology Efficient and precise gene editing, convenient operation, and multiplex targeted modification |
| Gene Overexpression | IOS Overexpression Stable Cell Line Construction Service | Uses mature IOS recombination technology Site-specific integration, non-random integration Stable inheritance; genes are not lost during passaging The site-specific integration site is a high-expression site, resulting in high gene expression Multiple genes can be integrated simultaneously to achieve multi-gene co-expression |
| Gene Silencing | IOS Silencing Stable Cell Line Construction Service | Uses mature IOS recombination technology shRNA is site-specifically integrated, not randomly integrated shRNA is stably inherited, and the target gene is not lost during passaging Gene silencing efficiency remains consistent during cell passaging |
| Site-Specific Gene Integration | Precise Site-Specific Integration Cell Line Construction Service | Using IOS technology, oligonucleotide recognition sequences targeting the target gene can guide conformational changes in the genome at the target site Homologous recombination is used to insert functional genes into the genomic target site, accurately achieving site-specific integration of the target gene |
Service Workflow:







